CORONARY ATHEROSCLEROSIS
Clinical trials for CORONARY ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new CORONARY ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for CORONARY ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail aims to reverse early heart disease
Disease control Not yet recruitingThis Phase 3 trial will test whether a combination of three cholesterol-lowering drugs—bempedoic acid, ezetimibe, and a high-intensity statin—can reduce and stabilize plaque buildup in the coronary arteries. The study enrolls 103 adults with coronary atherosclerosis who have neve…
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug YN001 aims to shrink artery plaque in heart disease trial
Disease control Not yet recruitingThis study tests a drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive weekly injections of YN001 or a placebo for 13 weeks. The main goal is to see if YN001 reduces plaque volume in the arteries, as measured by a…
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Weight-Loss drug may also protect heart arteries
Disease control Not yet recruitingThis study tests whether mazdutide, a weekly injection that helps with weight loss, can slow the buildup of fatty plaque in the heart arteries of 116 overweight or obese adults with coronary heart disease. Participants will receive either the drug or a placebo for 52 weeks, and d…
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC